Raptor Pharm (RPTP) Reports Q4 Loss of $0.20
Tweet
Share
E-mailGet Alerts RPTP Hot Sheet
Join SI Premium – FREE
Raptor Pharm (NASDAQ: RPTP) reported Q4 EPS of ($0.20), versus ($0.11) reported last year.
For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.
For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
